Gianna M. D'elia

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Short BRAF+MEK coinhibition, alone and combined with anti-CD20 immunotherapy, in relapsed or refractory hairy cell leukemia: An investigator-sponsored multi-center phase 2 clinical trial.

Short BRAF+MEK coinhibition, alone and combined with anti-CD20 immunotherapy, in relapsed or refractory hairy cell leukemia: An investigator-sponsored multi-center phase 2 clinical trial.

Journal: HemaSphere

Published: April 30, 2026

Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants.

Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants.

Journal: European journal of haematology

Published: April 27, 2026

Prognostic impact of treatment-related and geriatric factors in older patients with classic Hodgkin lymphoma: A real-life cohort study.

Prognostic impact of treatment-related and geriatric factors in older patients with classic Hodgkin lymphoma: A real-life cohort study.

Journal: British journal of haematology

Published: November 16, 2025

Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R).

Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R).

Journal: HemaSphere

Published: September 08, 2025

Targetable Mutations in BRAF V600E-Negative Hairy-Cell Leukemia.

Targetable Mutations in BRAF V600E-Negative Hairy-Cell Leukemia.

Journal: The New England journal of medicine

Published: April 11, 2025

Predicting thrombotic risk in patients with classical Hodgkin lymphoma: Thro-HL multicenter study.

Predicting thrombotic risk in patients with classical Hodgkin lymphoma: Thro-HL multicenter study.

Journal: HemaSphere

Published: February 04, 2025

The Impact of Radiotherapy and Attenuated Chemotherapy Regimens in Older Patients with Classic Hodgkin Lymphoma: A Real-Life Study from the ReLLi Network.

The Impact of Radiotherapy and Attenuated Chemotherapy Regimens in Older Patients with Classic Hodgkin Lymphoma: A Real-Life Study from the ReLLi Network.

Journal: Cancers

Published: January 20, 2025

A case of posterior reversible encephalopathy syndrome (PRES) in an elderly patient with advanced classical Hodgkin Lymphoma during frontline treatment with brentuximab vedotin plus AVD.

A case of posterior reversible encephalopathy syndrome (PRES) in an elderly patient with advanced classical Hodgkin Lymphoma during frontline treatment with brentuximab vedotin plus AVD.

Journal: Leukemia & lymphoma

Published: July 27, 2024

Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study.

Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study.

Journal: Mediterranean journal of hematology and infectious diseases

Published: July 07, 2023

Myelodysplastic clones arising post chimeric antigen receptor t cell therapy (car-t) procedure: a casuality or a new entity?

Myelodysplastic clones arising post chimeric antigen receptor t cell therapy (car-t) procedure: a casuality or a new entity?

Journal: Annals of hematology

Published: April 13, 2023

SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia.

SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia.

Journal: British journal of haematology

Published: September 29, 2022

Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study.

Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study.

Journal: Hematological oncology

Published: August 04, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026